OOIR: Observatory of International Research

Papers

(The H4-Index of Viruses-Basel is 72. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays	589
Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution	437
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention	323
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2	295
A Roadmap for Genome-Based Phage Taxonomy	273
VIRIDIC—A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses	256
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms	240
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner	222
Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design	221
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation	183
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice	179
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters	179
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions	173
Comparison of Rapid Antigen Tests for COVID-19	162
Deploying Machine and Deep Learning Models for Efficient Data-Augmented Detection of COVID-19 Infections	147
Dengue: A Minireview	145
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?	145
In Silico Discovery of Candidate Drugs against Covid-19	143
Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection	133
Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy	129
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)	127
ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?	125
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease	124
Highly Pathogenic Avian Influenza Viruses at the Wild–Domestic Bird Interface in Europe: Future Directions for Research and Surveillance	123
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2	120

Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic	118
Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?	118
Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2	114
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19	114
The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor	113
Mutations and Evolution of the SARS-CoV-2 Spike Protein	112
Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro	111
SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production	110
Curcumin as an Antiviral Agent	108
SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA	104
The Advantages and Challenges of Using Endolysins in a Clinical Setting	103
Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-	102
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications	102
Silencing and Transcriptional Regulation of Endogenous Retroviruses: An Overview	101
Herpes zoster: A Review of Clinical Manifestations and Management	101
Here, There, and Everywhere: The Wide Host Range and Geographic Distribution of Zoonotic Orthopoxviruses	101
Neutralizing Antibody Therapeutics for COVID-19	96
The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities	94
Propagation, Inactivation, and Safety Testing of SARS-CoV-2	93
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies	93
Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs	90
Dance with the Devil: Stress Granules and Signaling in Antiviral Responses	90
The Spike of Concern—The Novel Variants of SARS-CoV-2	89
Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19	88
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner	88
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies	87
West Nile Virus Epidemic in Germany Triggered by Epizootic Emergence, 2019	83
A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture	83
Coronavirus Infections in Companion Animals: Virology, Epidemiology, Clinical and Pathologic Features	83
Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak	82
African Swine Fever in Wild Boar in Europe—A Review	82
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations	82
Potential Antiviral Options against SARS-CoV-2 Infection	81
Nipah Virus: Past Outbreaks and Future Containment	81
Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature	81
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues	81
Liquid Biomolecular Condensates and Viral Lifecycles: Review and Perspectives	79
Lentiviral Vector Bioprocessing	77
The Mechanism behind Influenza Virus Cytokine Storm	76
Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2	76
Aphid Transmission of Potyvirus: The Largest Plant-Infecting RNA Virus Genus	74
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light	74
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA	73
SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP	73
The Interplay between Adeno-Associated Virus and Its Helper Viruses	73
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188	73
Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein	72
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2	72
Antiviral Activity Exerted by Natural Products against Human Viruses	72